Quarterly report pursuant to Section 13 or 15(d)

Revenue (Details Narrative)

v3.22.2.2
Revenue (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Disaggregation of Revenue [Line Items]        
Revenue recognized $ 494,000 $ 561,000 $ 6,138,000 $ 6,635,000
Revenue information related to variable consideration constraint     The Company’s revenue for the three months ended September 30, 2022 included approximately $384,000 recognized within the Company’s Treatment Segment and $148,000 recognized within the Company’s Services Segment that resulted from cumulative catch-up adjustments in transaction price from performance obligations satisfied or partially satisfied in the prior periods that had been constrained. During the three months ended September 30, 2021, the Company recognized approximately $1,286,000 in revenue from a request for equitable adjustment (“REA”) in its Treatment Segment that resulted in cumulative catch-up adjustment in transaction price that had been constrained in prior period.  
Revenue recognized 18,472,000 15,797,000 $ 53,842,000 $ 55,075,000
Treatment Segment [Member]        
Disaggregation of Revenue [Line Items]        
Revenue recognized 384,000 $ 1,286,000    
Services Segment [Member]        
Disaggregation of Revenue [Line Items]        
Revenue recognized $ 148,000